Sheng Yao

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

Jun Wang, Miguel F. Sanmamed, Ila Datar et al. · Cell · 2018 · 883 citations

Life Sciences, Immunology, Molecular Biology +7

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

Kristin J. Lastwika, Willie Wilson, Qing Kay Li et al. · Cancer Research · 2015 · 776 citations

Medicine, Immunology, Oncology +17

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Zixian Wang, Chengxu Cui, Jun Yao et al. · Cancer Cell · 2022 · 565 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Durable Cancer Regression Off-Treatment and Effective Reinduction Therapy with an Anti-PD-1 Antibody

Evan J. Lipson, William H. Sharfman, Charles G. Drake et al. · Clinical Cancer Research · 2012 · 543 citations

Medicine, Immunology, Oncology +17

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

Takeshi Azuma, Sheng Yao, Gefeng Zhu et al. · Blood · 2008 · 541 citations · Full text

Life Sciences, Cancer Biology, Oncology +8